Skip to main content

CORRECTION article

Front. Med., 15 January 2025
Sec. Infectious Diseases: Pathogenesis and Therapy
Volume 12 - 2025 | https://doi.org/10.3389/fmed.2025.1561115
This article is part of the Research Topic SARS-CoV-2 Vaccines Beyond the Pandemic Era View all 17 articles

Expression of concern: Evaluation of post-COVID mortality risk in cases classified as severe acute respiratory syndrome in Brazil: a longitudinal study for medium and long term

This article is a correction to:

  1. Evaluation of post-COVID mortality risk in cases classified as severe acute respiratory syndrome in Brazil: a longitudinal study for medium and long term Authors

    1. Read original article
\r\nFrontiers Editorial Office Frontiers Editorial Office*

An expression of concern on
Evaluation of post-COVID mortality risk in cases classified as severe acute respiratory syndrome in Brazil: a longitudinal study for medium and long term

by Rodrigues, N. C. P., and Andrade, M. K. d. N. (2024). Front. Med. 11:1495428. doi: 10.3389/fmed.2024.1495428

With this notice, Frontiers states its awareness of concerns regarding the content of the article “Evaluation of post-COVID mortality risk in cases classified as severe acute respiratory syndrome in Brazil: a longitudinal study for medium and long term” published on 18th December 2024. Our Research Integrity team will conduct an investigation in full accordance with our procedures. The situation will be updated as soon as the investigation is complete.

Citation: Frontiers Editorial Office (2025) Expression of concern: Evaluation of post-COVID mortality risk in cases classified as severe acute respiratory syndrome in Brazil: a longitudinal study for medium and long term. Front. Med. 12:1561115. doi: 10.3389/fmed.2025.1561115

Received: 15 January 2025; Accepted: 15 January 2025;
Published: 15 January 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, cmVzZWFyY2guaW50ZWdyaXR5QGZyb250aWVyc2luLm9yZw==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.